Pharmacists in Hubbard, Ohio


13 Pharmacists found in Hubbard
male pharmacist

Dr. Adam Marc Jablonski, PHARM.D.


Pharmacist
147 W Liberty St, Hubbard, OH 44425
330-534-1907    

female pharmacist

Aseel Nasser Ramahi


Pharmacist
147 W Liberty St, Hubbard, OH 44425
330-797-9485    

male pharmacist

Brendan Shinosky, PHARM. D


Pharmacist
147 W Liberty St, Hubbard, OH 44425
330-534-1907    



male pharmacist

Mr. Brent Devlin Groscost, RPH


Pharmacist
15 S Main St, Hubbard, OH 44425
330-534-4519     330-534-4572

female pharmacist

Janice Marie Gherardi


Pharmacist
134 Youngstown Hubbard Rd, Hubbard, OH 44425
330-534-3141    

male pharmacist

Dr. John Joseph Jablonski, PHARM.D.


Pharmacist
147 W Liberty St, Hubbard, OH 44425
330-534-1907    

male pharmacist

Kevin Mccarthy


Pharmacist
147 W Liberty St, Hubbard, OH 44425
330-534-1907    

male pharmacist

Mathew Walter Newton, PHARMD.


Pharmacist
147 W Liberty St, Hubbard, OH 44425
330-534-1907    

female pharmacist

Dr. Melissa Stanton, PHARMD


Pharmacist
15 S Main St, Hubbard, OH 44425
330-534-4519    

female pharmacist

Patricia Ann Tomko, RPH


Pharmacist
147 W Liberty St, Hubbard, OH 44425
330-534-1907     330-534-8773

male pharmacist

Dr. Robert Howard Flowers, OD



104 N Main St, Hubbard, OH 44425
330-534-6785    

female pharmacist

Dr. Tara Lynn Hartman, PHARMD, RPH


Pharmacist
134 Youngstown Hubbard Rd, Hubbard, OH 44425
330-534-3141    

male pharmacist

Zenon Ostap Forosty, PHARMACIST


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
147 W Liberty St, Hubbard, OH 44425
330-534-1907    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.